| Stage | AEBI | % of rev | SAFE | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $496M | 100.00% | $119M | 100.00% | AEBI ×4.18 |
| Gross profit | $97M | 19.60% | $116M | 97.87% | SAFE +78.3pp |
| Operating income | $27M | 5.45% | $29M | 24.70% | SAFE +19.3pp |
| Pre-tax income | $15M | 3.09% | $33M | 27.66% | SAFE +24.6pp |
| Net income | $10M | 2.11% | $31M | 26.41% | SAFE +24.3pp |
| Stage | AEBI | SAFE | Gap · A − B |
|---|---|---|---|
| Revenue | $496M100.00% | $119M100.00% | AEBI ×4.18 |
| Gross profit | 19.60%$97M | 97.87%$116M | SAFE +78.3pp |
| Operating income | 5.45%$27M | 24.70%$29M | SAFE +19.3pp |
| Pre-tax income | 3.09%$15M | 27.66%$33M | SAFE +24.6pp |
| Net income |
| 2.11%$10M |
| 26.41%$31M |
| SAFE +24.3pp |
No shared counterparties.